Cloning and expression of human haptoglobin subunits in Escherichia coli: Delineation of a major antioxidant domain

Protein Expression and Purification

Volumn 52, Issue 2, 2007, Pages 356-362

  Lai, I Hsiang ^a   Tsai, Tsung I ^a   Lin, Hong Huei ^a   Lai, Wei Yen ^a   Mao, Simon J T ^a,b  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

and chains; Antioxidant domain; Circular dichroism; Cloning; Human haptoglobin; Mini Hp fragment; Monoclonal antibody; Structure

Indexed keywords

ANTIOXIDANT; HAPTOGLOBIN; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ARTICLE; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANTIOXIDANTS; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION; HAPTOGLOBINS; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI;

EID: 33846431236     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.09.012     Document Type: Article

References (35)

1. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., and Kooistra T. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-{alpha} activator fenofibrate. J. Biol. Chem. 279 (2004) 16154-16160
2. Raijmakers M.T., Roes E.M., te Morsche R.H., Steegers E.A., and Peters W.H. Haptoglobin and its association with the HELLP syndrome. J. Med. Genet. 40 (2003) 214-216
3. Wang Y., Kinzie E., Berger F.G., Lim S.K., and Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep. 6 (2001) 379-385
4. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H., Law S.K.A., and Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 409 (2001) 198-201
5. Langlois M.R., and Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42 (1996) 1589-1600
6. Tseng C.F., Lin C.C., Huang H.Y., Liu H.C., and Mao S.J.T. Antioxidant role of human haptoglobin. Proteomics 4 (2004) 2221-2228
7. Haugen T.H., Hanley J.M., and Heath E.C. Haptoglobin: a novel mode of biosynthesis of a liver secretory glycoprotein. J. Biol. Chem. 256 (1981) 1055-1057
8. Kurosky A., Barnett D.R., Lee T.H., Touchstone B., Hay R.E., Arnott M.S., Bowman B.H., and Fitch W.M. Covalent structure of human haptoglobin: a serine protease homolog. Proc. Natl. Acad. Sci. USA 77 (1980) 3388-3392
9. McGill J.R., Yang F., Baldwin W.D., Brune J.L., Barnett D.R., Bowman B.H., and Moore C.M. Localization of the haptoglobin alpha and beta genes (HPA and HPB) to human chromosome 16q22 by in situ hybridization. Cytogenet. Cell Genet. 38 (1984) 155-157
10. Bowman B.H., and Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv. Hum. Genet. 12 (1982) 189-261
11. Wejman J.C., Hovsepian D., Wall J.S., Hainfeld J.F., and Greer J. Structure and assembly of haptoglobin polymers by electron microscopy. J. Mol. Biol. 174 (1984) 343-368
12. Engstrom G., Lind P., Hedblad B., Wollmer P., Stavenow L., Janzon L., and Lindgarde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 106 (2002) 2555-2560
13. Miyoshi H., Ohshiba S., Matsumoto A., Takada K., Umegaki E., and Hirata I. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Am. J. Gastroenterol. 86 (1991) 1638-1641
14. Hochberg I., Roguin A., Nikolsky E., Chanderashekhar P.V., Cohen S., and Levy A.P. Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 161 (2002) 441-446
15. Wicher K.B., and Fries E. Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein. Proc. Natl. Acad. Sci. USA 101 (2004) 14390-14395
16. Chen W.L., Huang M.T., Liu H.C., Li C.W., and Mao S.J.T. Distinction between dry and raw milk using monoclonal antibodies prepared against dry milk proteins. J. Dairy Sci. 87 (2004) 2720-2729
17. Tseng C.F., Huang H.Y., Yang Y.T., and Mao S.J.T. Purification of human haptoglobin 1-1, 2-1, and 2-2 using monoclonal antibody affinity chromatography. Protein Expr. Purif. 33 (2004) 265-273
18. Brune J.L., Yang F., Barnett D.R., and Bowman B.H. Evolution of haptoglobin: comparison of complementary DNA encoding Hp alpha 1S and Hp alpha 2FS. Nucleic Acids Res. 12 (1984) 4531-4538
19. Lowry O.H., Rosenbrough N.J., Farr R., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Song C.Y., Chen W.L., Yang M.C., Huang J.P., and Mao S.J.T. Epitope mapping of a monoclonal antibody specific to bovine dry milk: involvement of residues 66-76 of strand D in thermal denatured beta-lactoglobulin. J. Biol. Chem. 280 (2005) 3574-3582
21. Chen W.L., Liu W.T., Yang M.C., Hwang M.T., Tsao J.H., and Mao S.J.T. A novel conformation-dependent monoclonal antibody specific to the native structure of beta-lactoglobulin and its application. J. Dairy Sci. 89 (2006) 912-921
22. Mao S.J.T., Sparrow J.T., Gotto A.M., and Jackson R.L. The phospholipid-binding and immunochemical properties of amidinated, guanidinated and acetylated apolipoprotein A-II. Biochim. Biophys. Acta 617 (1980) 245-253
23. Mao S.J.T., Yates M.T., and Jackson R.L. Antioxidant activity and serum levels of probucol and probucal metabolites. Methods Enzymol. 234 (1994) 505-513
24. Barnhart R.L., Busch S.J., and Jackson R.L. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. Lipid Res. 30 (1989) 1703-1710
25. Bujard H., Gentz R., Lanzer M., Stüber D., Müller M., Ibrahimi I., Häuptle M.T., and Dobberstein B. A T5 promotor based transcription-translation system for the analysis of proteins in vivo and in vitro. Methods Enzymol. 155 (1987) 416-433
26. Goldstein L.A., and Heath E.C. Nucleotide sequence of rat haptoglobin cDNA. Characterization of the alpha beta-subunit junction region of prohaptoglobin. J. Biol. Chem. 259 (1984) 9212-9217
27. Hanley J.M., and Heath E.C. A novel proteolytic activity in serum processes rat prohaptoglobin. Arch. Biochem. Biophys. 239 (1985) 404-419
28. Colangeli R., Heijbel A., Williams A.M., Manca C., Chan J., Lyashchenko K., and Gennaro M.L. Three-step purification of lipopolysaccharide-free polyhistidine-tagged recombinant antigens of Myobacterium tuberculosis. J. Chromatogr. B. 714 (1998) 223-235
29. Sia Y.T., Lapointe N., Parker T.G., Tsoporis J.N., Deschepper C.F., Calderone A., Pourdjabbar A., Jasmin J.F., Sarrazin J.F., Liu P., Adam A., Butany J., and Rouleau J.L. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 105 (2002) 2549-2555
30. Roy K., Saha A., De K., and Sengupta C. Evaluation of probucol as suppressor of ceftizoxime induced lipid peroxidation. Acta Pol. Pharm. 59 (2002) 231-234
31. Kim M.H., Cha K.S., Han J.Y., Kim H.J., and Kim J.S. Effect of antioxidant probucol for preventing stent restenosis. Catheter. Cardiovasc. Interv. 57 (2002) 424-428
32. Inazu A., Koizumi J., Kajinami K., Kiyohar T., Chichibu K., and Mabuchi H. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. Atherosclerosis 145 (1999) 405-413
33. Stocker R. Dietary and pharmacological antioxidants in atherosclerosis. Curr. Opin. Lipidol. 10 (1999) 589-597
34. Mao S.J.T., Yates M.T., Parker R.A., Chi E.M., and Jackson R.L. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic rabbits using a probucol analog (MDL 29,311) that does not lower serum cholesterol. Arterioscler. Thromb. 11 (1991) 1266-1275
35. Mao S.J.T., Yates M.T., Rechtin A.E., Jackson R.L., and van Sickle W.A. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J. Med. Chem. 34 (1991) 298-302